Real World Clinical Effectiveness and Safety of Ozanimod in the Treatment of Ulcerative Colitis: 1-Year Follow-Up from a Tertiary Center-Reference-Cited by-同舟云学术

Real World Clinical Effectiveness and Safety of Ozanimod in the Treatment of Ulcerative Colitis: 1-Year Follow-Up from a Tertiary Center

Published:2023-12-12 Issue: Volume: Page:
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Cohen Nathaniel A.,Choi David,Garcia Nicole,Choi Natalie K.,Picker Emma,Krugliak Cleveland Noa,Cohen Russell D.,Dalal Sushila R.,Pekow Joel,Rubin David T.^ORCID

Funder

Maor Foundation

Gastro-Intestinal Research Foundation

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

https://link.springer.com/content/pdf/10.1007/s10620-023-08178-8.pdf

Reference26 articles.

1. Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG Clinical Guideline: Ulcerative Colitis in Adults. Am J Gastroenterol. 2019;114:384–413. https://doi.org/10.14309/AJG.0000000000000152.

2. Marrero F, Qadeer MA, Lashner BA. Severe Complications of Inflammatory Bowel Disease. Med Clin North Am. 2008;92:671–686. https://doi.org/10.1016/j.mcna.2007.12.002.

3. Knowles SR, Graff LA, Wilding H, Hewitt C, Keefer L, Mikocka-Walus A. Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses - Part i. Inflamm Bowel Dis. 2018;24:742–751. https://doi.org/10.1093/ibd/izx100.

4. Singh S, George J, Boland BS, Casteele N Vande, Sandborn WJ. Primary non-response to tumor necrosis factor antagonists is associated with inferior response to second-line biologics in patients with Inflammatory bowel diseases: A systematic review and meta-analysis. J Crohn’s Colitis. 2018;12:635–643. doi:https://doi.org/10.1093/ecco-jcc/jjy004

5. Peyrin-Biroulet L, Christopher R, Behan D, Lassen C. Modulation of sphingosine-1-phosphate in inflammatory bowel disease. Autoimmun Rev. 2017;16:495–503. https://doi.org/10.1016/J.AUTREV.2017.03.007.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics of S1P receptor modulators in the treatment of ulcerative colitis;Expert Opinion on Drug Metabolism & Toxicology;2024-09-12

2. Small Molecule Therapy for Inflammatory Bowel Disease: JAK Inhibitors and S1PR Modulators;The Korean Journal of Gastroenterology;2024-08-25

3. Modern Advanced Therapies for Inflammatory Bowel Diseases: Practical Considerations and Positioning;Clinical Gastroenterology and Hepatology;2024-08

4. Concise Commentary: Ozanimod in Real Life—Plus ça Change, Plus C’est la Même Chose;Digestive Diseases and Sciences;2023-12-12